drugset / Trial / NCT02016235
Role Of Phosphorus And FGF 23 In Patients With Dent Disease
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Patients with Dent disease have suppressed levels of FGF 23 which contributes to hypercalciuria, kidney stones, nephrocalcinosis and renal failure. Supplementation with phosphorus may reduce hypercalciuria.
Timeline
- Start
- 2014-09
- Primary completion
- 2019-01
- Completion
- 2019-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | phosphate | Unknown | 250 mg | Oral |